Luminsa, Lian Jay L.
HRN: 22-34-04 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/13/2022
CEFTRIAXONE 1G (VIAL)
12/13/2022
12/19/2022
IV
2g
OD
Seizure Disorder Prob Sec To TB Meningitis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes